Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-10-12

Clinical Trial Update: Evaluation of Safety and Performance of the Orbix Breast Lift System [NA]

View source ↗

Summary

The clinical trial evaluating the Orbix Breast Lift System for breast ptosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orbix Breast Lift System

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Breast Ptosis | NA | Status: WITHDRAWN